GALECTIN THERAPEUTICS INC - COM NEW (GALT)

Historical Portfolio Holders from Q1 2014 to Q3 2024

All holders as of June 30, 2024
Q2 2024
Type / Class
Equity / COM NEW
Shares, excl. options Q2 2024
9.42M
Holdings value Q2 2024
$21.3M
Value change Q2 2024
+$4.01M
Grand Portfolio weight change Q2 2024
+0%
Number of holders
71
Number of buys Q2 2024
4
Number of sells Q2 2024
-2
Average buys Q2 2024 %
+0%
Average sells Q2 2024 %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 968K $2.66M +$38.1K $2.75 17
2024 Q2 9.42M $21.3M +$4.01M $2.26 71
2024 Q1 7.59M $18.1M +$1.15M $2.39 58
2023 Q4 7.22M $12M -$3.15M $1.66 66
2023 Q3 9.05M $17.4M +$3.46M $1.92 59
2023 Q2 7.27M $10.5M +$114K $1.44 58
2023 Q1 7.16M $15M +$222K $2.10 55
2022 Q4 7.11M $8.03M +$165K $1.13 58
2022 Q3 6.93M $11.3M -$167K $1.63 52
2022 Q2 7.05M $9.23M -$580K $1.31 54
2022 Q1 7.46M $12M -$281K $1.61 54
2021 Q4 7.33M $15.2M -$499K $2.07 54
2021 Q3 7.29M $28.2M -$2.24M $3.88 67
2021 Q2 7.89M $25.3M -$5.9M $3.20 72
2021 Q1 9.41M $20.4M -$1.89M $2.17 69
2020 Q4 10.8M $24M +$1.27M $2.24 75
2020 Q3 10M $26.8M -$334K $2.67 68
2020 Q2 10.2M $31.1M +$1.53M $3.06 73
2020 Q1 9.68M $19M -$1.08M $1.96 73
2019 Q4 10.1M $28.8M +$1.85M $2.86 76
2019 Q3 9.39M $34.4M +$3.02M $3.67 75
2019 Q2 8.48M $35.2M +$4.36M $4.15 73
2019 Q1 7.3M $37.3M +$9.16M $5.11 63
2018 Q4 5.73M $19.7M -$2.55M $3.43 57
2018 Q3 6.01M $36.1M +$2.41M $6.01 59
2018 Q2 5.57M $35.5M +$4.18M $6.36 67
2018 Q1 4.98M $23.6M +$6.25M $4.74 58
2017 Q4 3.73M $12.5M -$431K $3.34 46
2017 Q3 3.79M $8.08M +$14.3K $2.13 43
2017 Q2 3.97M $9.77M +$859K $2.46 46
2017 Q1 3.63M $8.34M +$1.93M $2.30 39
2016 Q4 2.84M $2.78M -$227K $0.98 34
2016 Q3 3.03M $3.43M -$603K $1.13 41
2016 Q2 3.49M $5.12M -$570K $1.47 42
2016 Q1 3.48M $4.96M -$243K $1.43 39
2015 Q4 3.57M $5.85M +$1.25M $1.64 47
2015 Q3 2.58M $6.05M -$1.68M $2.34 41
2015 Q2 3.33M $9.08M -$2.17M $2.73 53
2015 Q1 4.06M $13.6M +$1.02M $3.35 57
2014 Q4 3.76M $13M -$3.1M $3.47 58
2014 Q3 4.28M $21.5M -$4.78M $5.03 60
2014 Q2 4.24M $58.6M +$8.45M $13.81 64
2014 Q1 3.54M $53.9M +$32.4M $15.31 52